COVER STORY
How can BD Cathena help reduce infection risk for patients and staff?
The design of BD Cathena not only eliminates the potential infection risk associated with ports, but also reduces accidental blood exposure for patients and healthcare workers through the unique BD Multiguard technology. Indeed, this multi- use blood control technology helps prevent blood leakages, thereby decreasing the associated risk of exposure to blood borne pathogens. A passive needle shield also automatically covers the needle after use, protecting healthcare workers against needle-stick injuries and exposure to blood.
How can BD Cathena improve the overall patient experience?
BD Vialon™ biomaterial softens and becomes more pliable while in the vein, which can lead to a reduced number of additional devices required and an enhanced patient experience. The use of this highly flexible polymer material makes the catheter easier to place and advance on a wider cross-section of patients,7,8
with the potential
to reduce risk of vein wall penetration. The combination of the ultra-smooth surface and lubrication process also helps reduce the risk of mechanical phlebitis and infiltration, while fewer restarts due to kinking is a further advantage.7,9 increases dwell time7
Ultimately, this design and helps avoid the
pain caused by repeated peripheral cannula placement thus improving the patient’s experience.
How can the solution reduce costs and improve efficiency for your hospital?
BD Cathena has the potential to deliver significant time savings for busy healthcare professionals. The average time to clean up a blood leakage is 2.5 minutes.10
However,
as BD Multiguard™ technology decreases such leakages, the device has the potential to save valuable time for patient care. This is in addition to a 29% reduction in the time taken to place the cannula11
– with
rates of intravenous catheter insertion failure and unscheduled restarts reported to range from 33% to 69%, the efficiencies created can be significant.12
Hospitals have a duty of care to take action to protect staff and patients from needle-stick injury, but there are also financial implications associated with time off work and increased costs of treating infection. This is is addition to potential litigation and loss of reputation. The mean aggregate (direct and indirect) costs of one needle-stick injury is estimated to cost around £596 (range £159–£1,350),13 while the cost savings from managing fewer needle-stick injuries can generate a five- year overall saving of £46,494.14,15
This
make imperative the adoption of safety devices such as BD Cathena, with its compact passive safety mechanism offering a protection against needle-stick injuries.
SEPTEMBER 2019
Protecting vulnerable neonatal patients for immediate confirmation of vein entry.
Neonatal patients have immature immune systems, making them particularly vulnerable in the event of infection. The non-port design of Neoflon Pro Safety helps protect the catheter from ingress of microorganisms – reducing the risk of potentially devastating catheter-related bloodstream infections. The 24-gauge, safety shielded IV cannula is specially designed for smaller, fragile veins – making the challenging task of insertion much easier and less stressful for both patients and clinicians. First attempts at cannula insertion fails in 24-54% of children.16 However, Neoflon Pro Safety device shares many of the innovative design features incorporated in the BD Cathena range that help achieve successful vein entry, first time, as well as improving safety. These include: l BD Instaflash™ notched needle technology,
Ultimately, both BD Cathena and
Neoflon Pro Safety will help hospitals reduce rates of catheter-related complications, improve safety for staff and patients, increase clinicians’ confidence in performing cannulation, while answering national guidelines requirements on minimum number of ports and lumen. A fully referenced version can be seen at
www.clinicalservicesjournal.com
For more information scan the QR code here
E:
BDUK_customerservice@bd.com T: +44 (0)118 921 6000 W:
www.bd.com
WWW.CLINICALSERVICESJOURNAL.COM I 7
l Anti-rotation tab, to enhance cannulation control and provide tactile feedback during insertion.
l BD Vialon biomaterial, making it easier to insert and place the cannula. This also ensures longer dwell times and reduces the risk of mechanical phlebitis by up to 50%.17
l BD Multiguard technology to decrease blood leakages.
l Passive needle shield technology, which automatically covers the needle after cannulation, protecting against needle- stick injuries.
At hospitals where the device is now in use, clinicians have commented that the ease in which Neoflon Pro Safety is inserted has reduced unnecessary distress to this vulnerable population of patients.
t
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
